中國創新投資(01217.HK)認購洢人壹方(08305.HK)4,000萬元5%債券
中國創新投資(01217.HK)公布,中國創新與洢人壹方(08305.HK)訂立一份認購協議,中國創新同意向發行人洢人壹方認購本金總額為4,000萬元的5%票息三年期有抵押普通債券。
於同日,洢人壹方控股股東Advanced Pacific Enterprises Limited將其持有的51%洢人壹方股本,抵押予中國創新,作為洢人壹方按時及十足償還債券下的欠款並履行其在債券下義務的抵押擔保。於債券仍未贖回期間,中國創新可享有抵押股份股息的50%;若抵押人於債券仍未贖回期間出售抵押股份,中國創新可獲得售出抵押股份所得高於0.06元的收益的50%。
雙方達成上述交易的理由是洢人壹方在建築行業擁有豐富經驗,而中國創新在內地所投資的公司在建築行業擁有資源,雙方合作可幫助洢人壹方發展壯大內地的業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.